Simplex Trading
LLY icon

Simplex Trading’s Eli Lilly LLY Stock Holding History

Simplex Trading’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67M Sell
72,800
-94,300
-56% -$95.6M 0.04% 176
2025
Q4 		$180M Sell
167,100
-71,600
-30% -$68.5M 0.1% 84
2025
Q3 		$182M Sell
238,700
-67,900
-22% -$50.5M 0.09% 98
2025
Q2 		$239M Buy
306,600
+38,400
+14% +$29.8M 0.14% 72
2025
Q1 		$206M Sell
268,200
-130,800
-33% -$109M 0.13% 71
2024
Q4 		$285M Buy
399,000
+69,300
+21% +$57.4M 0.16% 64
2024
Q3 		$292M Sell
329,700
-81,600
-20% -$73.4M 0.17% 57
2024
Q2 		$372M Sell
411,300
-13,700
-3% -$11M 0.23% 42
2024
Q1 		$331M Buy
425,000
+101,500
+31% +$72.2M 0.19% 55
2023
Q4 		$189M Buy
323,500
+54,000
+20% +$31.5M 0.12% 80
2023
Q3 		$145M Sell
269,500
-80,100
-23% -$41.3M 0.11% 81
2023
Q2 		$164M Buy
349,600
+117,600
+51% +$49.3M 0.13% 71
2023
Q1 		$79.7M Sell
232,000
-9,200
-4% -$3.1M 0.07% 195
2022
Q4 		$88.2M Buy
241,200
+32,500
+16% +$11.5M 0.1% 166
2022
Q3 		$67.5M Buy
208,700
+53,500
+34% +$17M 0.08% 185
2022
Q2 		$50.3M Buy
155,200
+28,000
+22% +$8.4M 0.05% 244
2022
Q1 		$36.4M Sell
127,200
-77,000
-38% -$19.8M 0.03% 364
2021
Q4 		$56.4M Sell
204,200
-15,800
-7% -$4.01M 0.06% 254
2021
Q3 		$50.8M Buy
220,000
+25,900
+13% +$6.39M 0.05% 244
2021
Q2 		$44.5M Buy
194,100
+191,354
+6,968% +$38.4M 0.04% 261
2021
Q1 		$51.3M Buy
2,746
+1,769
+181% +$346K 0.09% 134
2020
Q4 		$16.5M Sell
977
-608
-38% -$90.8K 0.02% 407
2020
Q3 		$23.5M Sell
1,585
-461
-23% -$71.3K 0.03% 297
2020
Q2 		$33.6M Sell
2,046
-658
-24% -$101K 0.05% 195
2020
Q1 		$37.5M Buy
2,704
+447
+20% +$61.4K 0.07% 153
2019
Q4 		$29.7M Buy
2,257
+1,843
+445% +$214K 0.06% 193
2019
Q3 		$4.63M Sell
414
-1,692
-80% -$188K 0.01% 760
2019
Q2 		$23.3M Buy
2,106
+45
+2% +$5.3K 0.06% 204
2019
Q1 		$26.7M Buy
2,061
+556
+37% +$67.6K 0.07% 164
2018
Q4 		$17.4M Buy
1,505
+432
+40% +$48.3K 0.05% 223
2018
Q3 		$11.5M Buy
1,073
+668
+165% +$66.8K 0.04% 317
2018
Q2 		$3.46M Sell
405
-244
-38% -$20K 0.01% 765
2018
Q1 		$234K Sell
649
-343
-35% -$27.6K 0.01% 1138
2017
Q4 		$19K Sell
992
-201
-17% -$17.1K ﹤0.01% 3354
2017
Q3 		$99K Sell
1,193
-1,410
-54% -$116K ﹤0.01% 1715
2017
Q2 		$290K Buy
2,603
+1,396
+116% +$114K 0.01% 971
2017
Q1 		$208K Sell
1,207
-3,084
-72% -$247K 0.01% 1184
2016
Q4 		$777K Sell
4,291
-574
-12% -$42.7K 0.05% 344
2016
Q3 		$735K Buy
4,865
+2,307
+90% +$185K 0.05% 353
2016
Q2 		$247K Buy
2,558
+1,071
+72% +$80.6K 0.02% 873
2016
Q1 		$456K Buy
1,487
+695
+88% +$52.6K 0.04% 489
2015
Q4 		$54K Sell
792
-1,074
-58% -$89.1K ﹤0.01% 1853
2015
Q3 		$287K Buy
1,866
+1,199
+180% +$101K 0.02% 715
2015
Q2 		$92K Buy
667
+446
+202% +$34K 0.01% 1258
2015
Q1 		$22K Sell
221
-63
-22% -$4.49K ﹤0.01% 2257
2014
Q4 		$110K Buy
+284
New +$19.2K 0.01% 883

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Simplex Trading's LLY Position: Q1 2026 in Review

Simplex Trading sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,899 shares — an estimated $1.93M sold.

Simplex Trading first reported a position in LLY in Q4 2014 and held it in 21 quarters. The position peaked at $28.1M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Simplex Trading reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,899 Eli Lilly shares in Q1 2026, an estimated $1.93M.
  • Simplex Trading first reported a position in Eli Lilly in Q4 2014 and held it in 21 quarters.
  • Simplex Trading's Eli Lilly position peaked at $28.1M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.